Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175668 · ClinicalTrials.gov registry record · NA
Clonidine for Neonatal Abstinence Syndrome Study
A NA study, sponsored by Baystate Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01175668: Clinical Trial NA study, sponsored by Baystate Medical Center.
NCT01175668 is a NA study that was terminated before completion, run by Baystate Medical Center. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01175668, a NA study, was terminated before completion, sponsored by Baystate Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The study plans to compare the use of Clonidine versus Phenobarbital as an additional medication to neonatal morphine sulfate for treatment of newborn infants undergoing drug withdrawal symptoms due to mother's use of opioid drug use. The investigators hypothesis is that use of Clonidine will lead to shorter duration of treatment, hospital stay and thereby early discharge home.
Interventions
- DRUG Clonidine
- DRUG Phenobarbital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-10 |
| Phase | NA |
Why NCT01175668 stopped before completion
NCT01175668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Clonidine is the first listed.
NCT01175668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01175668 about?
NCT01175668 is a clinical study titled "Clonidine for Neonatal Abstinence Syndrome Study". The study plans to compare the use of Clonidine versus Phenobarbital as an additional medication to neonatal morphine sulfate for treatment of newborn infants undergoing drug withdrawal symptoms due to mother's use of opioid drug use. The investigators hypothesis is that use of Clonidine will lead t...
What is the current status of trial NCT01175668?
This trial is currently terminated. It is a NA study. The enrollment target is 68 participants. The study started on 2010-07. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01175668?
The interventions under investigation include: Clonidine (DRUG), Phenobarbital (DRUG).
Who is sponsoring clinical trial NCT01175668?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01175668's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia